| Literature DB >> 3339802 |
K E VanLandingham1, H B Marsteller, G W Ross, F G Hayden.
Abstract
Acyclovir sodium is the drug of choice for the treatment of herpes simplex encephalitis. We treated an immunocompetent patient with a ten-day course of intravenous acyclovir sodium at the recommended dosage of 10 mg/kg every eight hours for clinically apparent herpes simplex encephalitis. After marked improvement, his condition deteriorated four days after completing acyclovir therapy. A subsequent brain biopsy specimen disclosed acyclovir-sensitive herpes simplex virus type 1. A longer duration of acyclovir therapy (14 to 21 days) should be considered for treating herpes simplex encephalitis.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3339802
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272